Driving for change

Driving For Change: Zero‑Tolerance With Exemptions

NSW has taken a significant step by recognising that Cannabis presence is not impairment. But instead of adopting an impairment‑based model, the Government has created a narrow exemption that depends on registration, prescription proof, and administrative compliance. This report examines how the new framework reshapes driving laws while keeping zero‑tolerance largely intact.

New South Wales says it is fixing drug driving laws. But only if patients who use Cannabis for medical purpose join a government registry, upload their prescription, and complete a course.

For decades, NSW treated any detectable tetrahydrocannabinol (THC) as evidence of unsafe driving. The proposed reforms quietly abandon that assumption. For the first time, the Government accepts that THC presence alone is not proof of impairment.

That shift matters. But the model chosen to deliver it creates a narrow exemption rather than a genuine impairment‑based framework.

📜 The Details

The NSW Government is promoting its new drug driving reforms as landmark changes that will finally protect patients who use Cannabis for medical purpose. But when examined closely, the fine print reveals a deeper contradiction.

The Government now acknowledges the scientific principle that presence is not impairment. Yet the proposed model continues to punish THC presence for most drivers, unless they qualify for an administrative exemption.

This report explains how that contradiction works — and why it matters for evidence‑based policy.

🔬 Scientific Principle: Presence Is Not Impairment

For decades, the legal model assumed any detectable THC justified punishment. Introducing a laboratory threshold means the Government is accepting that measurable THC can exist without constituting an offence.

This is a significant conceptual shift, even though it applies only to eligible patients.

But the threshold is available only to those who meet additional administrative requirements.

⚠️ The Threshold

Under the proposed changes, patients who use Cannabis for medical purpose will not face automatic drug driving charges if laboratory testing shows THC below 50 nanograms per millilitre.

🪧 Presence ≠ Impairment Threshold: 50 ng per mL

This threshold matters because it formally rejects the idea that any THC equals impairment. It is the first crack in the zero-tolerance wall.

But the Government immediately restricts this scientific progress behind an eligibility gate.

🚧 The Eligibility Gate

To access the exemption, patients must:

  • register their prescription with Transport for NSW
  • provide proof of a valid prescription
  • complete a government-designed education program

The exemption is conditional, not medical. Eligibility depends on administrative compliance rather than clinical assessment.

No comparable registry exists for people prescribed opioids, benzodiazepines, or other potentially impairing medicines. The proposed model creates a separate administrative category for Cannabis patients alone.

This raises a clear principle:

The Government is not saying prescribed Cannabis patients are safe to drive. It is saying that only registered patients who satisfy additional administrative requirements may access the protection.

🪧 Mandatory Registration Mandatory Course Mandatory Prescription Proof

The Government calls this balancing safety. But it is really the same cultural reflex we have seen for decades — treating Cannabis as inherently risky, even when used legally and responsibly.

Driving for change

❌ The Three Strike System

If a registered patient tests above 50 nanograms per millilitre, they receive two warning notices — two strikes — before any legal penalties apply.

But those strikes apply even if the driver is unimpaired. Even if they are using their medication exactly as prescribed. Even if the THC detected is residual, predictable, and clinically irrelevant.

🪧 Three Strikes equals Administrative Punishment

Here is the core contradiction:

If THC below 50 ng per mL is accepted as consistent with lawful driving, then exceeding 50 ng per mL does not automatically establish impairment. Yet the three‑strike system still imposes escalating consequences based on THC concentration rather than demonstrated driving performance.

This is not impairment testing. It is presence-based enforcement with a softer landing.

⏳ The 24 Hour Suspension

Every registered patient who returns a positive roadside result is immediately prevented from driving, even though laboratory analysis may later confirm they committed no offence.

In practical terms, punishment still begins before any determination of legal liability.

Presence still equals punishment. The Government says the new regime distinguishes therapeutic use from recent use, but the 24-hour suspension contradicts that claim.

📢 The Model Frame

This reform protects a narrow slice of patients who use Cannabis for medical purpose. And it excludes the majority of real world Cannabis consumers, including:

  • patients without prescriptions
  • patients unable to obtain approval
  • patients unwilling to join a registry
  • patients who fear stigma or discrimination
  • interstate patients who cannot register
  • recreational consumers who are nevertheless unimpaired

The reform narrows the scope of zero-tolerance rather than replacing it.

🪧 This is not an impairment model. This is zero-tolerance with exemptions.

👉 The Logical Progression

Once the Government accepts that THC presence alone is not proof of impairment for registered medicinal Cannabis patients, an obvious question follows:

Why is THC presence sufficient evidence of impairment for everyone else?

Once the scientific principle is acknowledged, it becomes increasingly difficult to justify different legal standards based solely on a person’s administrative status.

The debate has shifted — but it has not yet been resolved.

Previous modelProposed model
Any detectable THC = offenceTHC below 50 ng per mL may not be an offence for eligible registered patients
No distinction between presence and impairmentGovernment now recognises presence and impairment are different concepts
Universal zero toleranceZero-tolerance retained, with limited exemptions for eligible patients

✍️ Conclusion

NSW has crossed an important scientific threshold by accepting that THC presence alone is not proof of impairment. But instead of replacing zero tolerance with an impairment‑based model, the reforms create a limited exemption available only to patients who satisfy additional administrative requirements.

The underlying enforcement philosophy remains largely unchanged.

🪧 The debate has shifted — but it has not yet been resolved.

Driving law logical progression

📚 References

  • Cannabis drivers not immediately penalised — The NSW Government outlines proposed driving reforms allowing registered patients with THC below 50 ng/mL to avoid immediate penalties, while retaining roadside suspensions and requiring registration, prescription proof, and completion of an education program.
  • Minns Labor Government to introduce commonsense medicinal cannabis driving reforms — The Minns Labor Government will introduce laws to Parliament to create a more commonsense approach for people using lawfully prescribed medicinal cannabis, while maintaining strong road safety protections.
  • Road Transport Act 2013 No 18 – Drug driving provisions — NSW legislation establishing the current presence‑based offence model, where any detectable THC constitutes an offence regardless of impairment.
  • 2024 NSW Drug Summit – Recommendations on medicinal cannabis and driving — Parliamentary recommendations calling for a medical defence framework and improved assessment methods for drivers using Cannabis for medical purpose.
  • Medicinal cannabis information for patients and the general public — Tasmania’s health department outlines access pathways, prescription requirements, and regulatory conditions for medicinal Cannabis, including the framework that underpins Tasmania’s statutory defence model.
  • NSW’s proposed medicinal cannabis drug‑driving defence questioned — Green Left reports on David Heilpern’s critique of the NSW Government’s proposed medicinal Cannabis driving reforms, examining the practical limitations of the statutory defence model and highlighting concerns about court burden, patient eligibility, and the continued reliance on presence‑based enforcement.
  • Lambert Initiative – Driving Research — The Lambert Initiative summarises current scientific evidence on Cannabis and driving, including impairment windows, tolerance effects, pharmacokinetics, and the limitations of presence‑based enforcement models.
  • THC Impairment Window Study (NCBI) — Acute and residual effects of cannabis on driving performance — Peer‑reviewed research examining how THC affects driving ability, showing that impairment is time‑limited while residual THC can persist without causing functional deficits.
  • Canada – Cannabis and Impairment — The Government of Canada explains how Cannabis affects driving, outlining impairment‑based enforcement, roadside assessment methods, and the distinction between recent use and residual THC.
  • New Zealand – Cannabis and Driving — Cannabis Clinic NZ explains New Zealand’s approach to Cannabis and driving, outlining impairment risks, legal obligations, saliva testing rules, and how medical Cannabis patients can navigate driving laws under the current enforcement framework.
  • Driving reform commentary — A Legalise Cannabis NSW video summarising concerns about the proposed medicinal Cannabis driving reforms, highlighting issues with eligibility, administrative compliance, and the continued reliance on presence‑based enforcement.
  • Medicinal cannabis access pathways — The Therapeutic Goods Administration explains how patients and prescribers access medicinal Cannabis through the Special Access Scheme, Authorised Prescriber Scheme, and clinical trials, outlining the regulatory requirements that determine prescription eligibility under Australian law.

✨ Topic Cluster

2. Legalisation Pathways & Structural Separation: Examining pathways to Cannabis legalisation, including descheduling, regulatory models, political incentives, and the structural reforms needed for a functional post‑prohibition system.

🏛️ Pillar Content

📌 Related Reports

👉 This Article

Driving For Change: Zero‑Tolerance With Exemptions — Driving reforms in NSW now accept that Cannabis presence is not impairment, yet still rely on zero‑tolerance with exemptions.

Share this article from here:
Tags